NO20054842L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20054842L
NO20054842L NO20054842A NO20054842A NO20054842L NO 20054842 L NO20054842 L NO 20054842L NO 20054842 A NO20054842 A NO 20054842A NO 20054842 A NO20054842 A NO 20054842A NO 20054842 L NO20054842 L NO 20054842L
Authority
NO
Norway
Prior art keywords
chemical connections
treatment
proliferative diseases
connections
chemical
Prior art date
Application number
NO20054842A
Other languages
English (en)
Inventor
Frederic Henri Jung
Andrew Austen Mortlock
Georges Rene Pasquet
Nicola Murdoch Heron
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20054842L publication Critical patent/NO20054842L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Kinazolinderivater med formel (I) for anvendelse ved behandling av proliferative sykdommer, så som kreft, og ved fremstilling av medikamenter for anvendelse ved behandling av proliferative sykdommer, og fremgangsmåter for fremstilling av dem, så vel som farmasøytiske preparater inneholdende dem som aktiv bestanddel.
NO20054842A 2003-04-16 2005-10-19 Kjemiske forbindelser NO20054842L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03290951 2003-04-16
PCT/GB2004/001614 WO2004094410A1 (en) 2003-04-16 2004-04-14 Chemical compounds

Publications (1)

Publication Number Publication Date
NO20054842L true NO20054842L (no) 2005-11-08

Family

ID=33305809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054842A NO20054842L (no) 2003-04-16 2005-10-19 Kjemiske forbindelser

Country Status (23)

Country Link
US (1) US7691867B2 (no)
EP (1) EP1613619B1 (no)
JP (1) JP4709139B2 (no)
KR (1) KR20060003351A (no)
CN (1) CN1809557B (no)
AR (1) AR043875A1 (no)
AT (1) ATE390422T1 (no)
AU (1) AU2004232527A1 (no)
BR (1) BRPI0409427A (no)
CA (1) CA2522079A1 (no)
CL (1) CL2004000797A1 (no)
CO (1) CO5640037A2 (no)
DE (1) DE602004012725T2 (no)
ES (1) ES2301981T3 (no)
HK (1) HK1086573A1 (no)
IS (1) IS8125A (no)
MX (1) MXPA05011076A (no)
NO (1) NO20054842L (no)
RU (1) RU2005135337A (no)
TW (1) TW200510392A (no)
UY (1) UY28271A1 (no)
WO (1) WO2004094410A1 (no)
ZA (1) ZA200508372B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2323215C2 (ru) * 2001-12-24 2008-04-27 Астразенека Аб Замещенные производные хиназолина как ингибиторы ауроракиназы
DK1847539T3 (da) * 2002-12-24 2009-11-09 Astrazeneca Ab Quinazolin-derivater
ES2308182T3 (es) * 2003-06-02 2008-12-01 Astrazeneca Ab Derivadosde (3-((quinazolin-4-il)amino)-1h-pirazol-1-il)acetamida y compuestos relacionados como inhibidores de quinasas aurora para el tratamiento de enfermedades proliferativas tales como el cancer.
UA85706C2 (en) 2004-05-06 2009-02-25 Уорнер-Ламберт Компани Ллси 4-phenylaminoquinazolin-6-yl amides
US20090036474A1 (en) * 2004-10-12 2009-02-05 Patrick Ple Quinazoline derivatives for use against cancer
AU2005293336B2 (en) 2004-10-12 2009-05-28 Astrazeneca Ab Quinazoline derivatives
WO2006040522A1 (en) * 2004-10-12 2006-04-20 Astrazeneca Ab Quinoline derivatives
US7713973B2 (en) 2004-10-15 2010-05-11 Takeda Pharmaceutical Company Limited Kinase inhibitors
PL1819698T3 (pl) 2004-11-17 2011-08-31 Rexahn Pharmaceuticals Inc Pochodne 1-[(6-podstawione alkoksychinoksalinylo)aminokarbonylo]-4-(hetero)arylopiperazyny
WO2006129064A1 (en) * 2005-05-28 2006-12-07 Astrazeneca Ab Quinazolines and their use as aurora kinase inhibitors
GB0510963D0 (en) * 2005-05-28 2005-07-06 Astrazeneca Ab Chemical compounds
JP2009508922A (ja) * 2005-09-22 2009-03-05 アストラゼネカ アクチボラグ ４−アミノピラゾール誘導体の製造方法
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
GB0601215D0 (en) * 2006-01-21 2006-03-01 Astrazeneca Ab Chemical compounds
WO2007099317A1 (en) * 2006-03-02 2007-09-07 Astrazeneca Ab Quinazoline derivatives
UY30183A1 (es) 2006-03-02 2007-10-31 Astrazeneca Ab Derivados de quinolina
WO2007113565A1 (en) * 2006-04-06 2007-10-11 Astrazeneca Ab Naphthyridine derivatives as anti-cancer agents
GB0609617D0 (en) * 2006-05-16 2006-06-21 Astrazeneca Ab Process & intermediate
SG175609A1 (en) 2006-10-09 2011-11-28 Takeda Pharmaceutical Kinase inhibitors
FR2908409B1 (fr) * 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
AR092289A1 (es) * 2011-11-14 2015-04-15 Sunshine Lake Pharma Co Ltd Derivados de aminoquinazolina y sus sales y metodos de uso
CN103012428A (zh) * 2013-01-08 2013-04-03 中国药科大学 4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
CN104098551B (zh) * 2013-04-03 2019-03-22 广东东阳光药业有限公司 作为欧若拉激酶抑制剂的取代喹唑啉类衍生物
CN103382158B (zh) * 2013-07-29 2015-11-18 张家港市大伟助剂有限公司 一种2-环戊基氨基乙醇的制备方法
BR112016005317A2 (pt) * 2013-09-19 2017-09-12 Centre Nat Rech Scient derivados de quinazolina e seu uso como inibidores de dna metiltransferase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
TW321649B (no) * 1994-11-12 1997-12-01 Zeneca Ltd
DE69622183D1 (de) * 1995-11-07 2002-08-08 Kirin Brewery Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen
WO2001021596A1 (en) * 1999-09-21 2001-03-29 Astrazeneca Ab Quinazoline derivatives and their use as pharmaceuticals
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
US6919338B2 (en) * 2000-06-28 2005-07-19 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors of aurora-2 kinase
RU2323215C2 (ru) * 2001-12-24 2008-04-27 Астразенека Аб Замещенные производные хиназолина как ингибиторы ауроракиназы
EP1548008A4 (en) * 2002-08-23 2008-08-06 Kirin Pharma Kk COMPOUND HAVING BETA-TRANSFORMING GROWTH FACTOR INHIBITORY ACTIVITY AND DRUG CONTAINING COMPOSITION
ATE412657T1 (de) 2002-12-24 2008-11-15 Astrazeneca Ab Therapeutische quinazolin-derivate
MXPA05006920A (es) * 2002-12-24 2006-02-10 Astrazeneca Ab Compuestos de quinazolina.
DK1847539T3 (da) * 2002-12-24 2009-11-09 Astrazeneca Ab Quinazolin-derivater
ES2308182T3 (es) * 2003-06-02 2008-12-01 Astrazeneca Ab Derivadosde (3-((quinazolin-4-il)amino)-1h-pirazol-1-il)acetamida y compuestos relacionados como inhibidores de quinasas aurora para el tratamiento de enfermedades proliferativas tales como el cancer.
TW200505452A (en) * 2003-06-17 2005-02-16 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
TW200510392A (en) 2005-03-16
CN1809557A (zh) 2006-07-26
EP1613619B1 (en) 2008-03-26
DE602004012725T2 (de) 2009-04-16
WO2004094410A1 (en) 2004-11-04
IS8125A (is) 2005-11-11
JP2006523660A (ja) 2006-10-19
CL2004000797A1 (es) 2005-05-27
CO5640037A2 (es) 2006-05-31
CN1809557B (zh) 2012-07-04
ZA200508372B (en) 2007-04-25
UY28271A1 (es) 2004-11-30
JP4709139B2 (ja) 2011-06-22
BRPI0409427A (pt) 2006-04-18
CA2522079A1 (en) 2004-11-04
ATE390422T1 (de) 2008-04-15
DE602004012725D1 (de) 2008-05-08
US20060270692A1 (en) 2006-11-30
US7691867B2 (en) 2010-04-06
AU2004232527A1 (en) 2004-11-04
KR20060003351A (ko) 2006-01-10
ES2301981T3 (es) 2008-07-01
AR043875A1 (es) 2005-08-17
HK1086573A1 (en) 2006-09-22
RU2005135337A (ru) 2006-06-10
EP1613619A1 (en) 2006-01-11
MXPA05011076A (es) 2006-01-24

Similar Documents

Publication Publication Date Title
NO20054842L (no) Kjemiske forbindelser
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
DK1636236T3 (da) Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
PL1687305T3 (pl) Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
NO20072259L (no) Heteroaryltiazoler og deres anvendelse som P13K-inhibitorer
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
HK1063185A1 (en) Quinoline derivatives and their use as tyrosine kinase inhibitors
NO330888B1 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom
NO20070570L (no) Forbindelser.
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
TW200634002A (en) Chemical compounds
NO20054360L (no) Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater
TW200716618A (en) Chemical compounds
AU2003281193A1 (en) Quinazoline derivatives for use in the treatment of cancer
NO20051444L (no) Medikament inneholdende disorazoler og derivater av disse for behandling av benigne og maligne tumorsykdommer.
TW200502236A (en) Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
ATE337826T1 (de) Simplifizierte sarcodictyn-derivate als anti- tumor-mittel
NO20072090L (no) Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II
NO20013901L (no) Umettede kolestanderivater og deres anvendelse for fremstilling av meioseregulerende medikamenter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application